title: [Treatment of multiple sclerosis with natalizumab (Tysabri) in a setting of melanoma].
authors.affiliation: Service de dermatologie, hôpital Fournier, 36 quai de la Bataille, Nancy cedex, France. jl.schmutz@chu-nancy.fr
authors.forename: J-L
authors.initials: JL
authors.lastname: Schmutz
authors.forename: A
authors.initials: A
authors.lastname: Barbaud
authors.forename: P
authors.initials: P
authors.lastname: Tréchot
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D006801:Humans; D008545:Melanoma / Q000139:chemically induced* / Q000276:immunology; D009103:Multiple Sclerosis / Q000188:drug therapy*; D000069442:Natalizumab
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069442:Natalizumab